RIGEL PHARMACEUTICALS, INC. (RIGL) Gross profit 2018–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual gross profit history from SEC filings — each fiscal year as reported.
$274.7MFY2025 · since FY2018: $44.2M → $274.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $274.7M | +71.0% |
| FY2024 | $160.6M | +46.3% |
| FY2023 | $109.8M | -7.4% |
| FY2022 | $118.5M | -20.0% |
| FY2021 | $148.2M | +37.5% |
| FY2020 | $107.7M | +84.5% |
| FY2019 | $58.4M | +32.0% |
| FY2018 | $44.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →